Newsroom

LNC Therapeutics announces the grant of the first worldwide patent relating to the therapeutic...

Mar 26, 2019

YSOPIA Bioscience Announces Enrollment and Treatment of First Volunteers in its Phase 1 Clinical...

Dec 7, 2020

YSOPIA Bioscience secures €1.55M in non-dilutive funding from Bpifrance and the European Regional...

Nov 17, 2020

We are looking for a R&D Microbiologist

Oct 13, 2020

LNC Therapeutics becomes YSOPIA Bioscience marking its transition to a clinical stage company

Sep 29, 2020

LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial...

Sep 8, 2020

Discovering the Therapeutic Potential of Keystone Bacteria in Treating Chronic Diseases

Apr 22, 2020